monolaurin?

Sounds interesting, I have not come across this before. I will look into it further.  But here's what I found on a quick dig....

http://search.lef.org/cgi-src-bin/MsmGo.exe?grab_id=0&pa ge_id=2981&query=lauric%20acid&hiword=ACIDA%20ACIDAN %20ACIDAS%20ACIDBASED%20ACIDIC%20ACIDIS%20ACIDITY%20ACIDO%20 ACIDON%20ACIDS%20LAURI%20LAURIA%20acid%20lauric%20

Monolaurin (Glycerol Monolaurate)
Chemically, Monolaurin is a monoglycerol ester of the saturated fatty acid lauric acid. Lauric fatty acids are present in many animals and plants and possess broad-spectrum activity against fungi and viruses. Lauric acid is also present in human adipose tissue, urine, milk, and amniotic fluid; cow's milk, butter, margarine, and in palm-kernel and coconut oil. Esterification of lauric acid with glycerin yields compounds more active than the fatty acid alone.

Monolaurin had virucidal activity against 14 human enveloped RNA and DNA viruses. Monolaurin removed all measurable infectivity by disintegrating the viral envelope as evidenced by electron micrographs. By disrupting the conformation of the lipid bilayer (or the envelope), Monolaurin prevents viral attachment to susceptible host cells. Viruses that contain an envelope are termed enveloped , whereas those that lack an envelope are referred to as naked . DNA viruses (including herpes viruses) have a loose, outer envelope, which contains lipids. RNA viruses are similar in that they have a double outer envelope or bilayer which contains essential lipids and glycoproteins structurally embedded in this envelope. Solubilization of the lipids and phospholipids in the envelope are key mechanisms by which Monolaurin's virucidal activity is expressed. It was calculated that Monolaurin had a >99.9% success rate against all 14 viruses tested.

Although Monolaurin alone has no effect on lymphocyte or macrophage functions, it does potentiate immunological events initiated by other triggering agents (mitogens, antigens, phagocytic stimuli, and lymphokines). Monolaurin is regarded as a virustatic. Virustatic agents directly block replication of viruses, so there is no subsequent development of drug resistance, but do not kill the virus. Monolaurin is effective against HSV-1 and -2, EBV, and CMV (which share lipid envelope characteristics) (Cohen et al. 1977; Sands et al. 1979; Kabara, 1980; Kohn et al. 1980).

Monolaurin has antiviral properties that allows its use without significant toxicity. No significant abnormalities have been noted in liver enzymes, leukocytes, red cells, hematocrit, hemoglobin, or platelets with Monolaurin therapy.

A suggested Monolaurin dosage is 6 (300-mg) capsules daily on an empty stomach (20 minutes before or 2 hours after a meal).